| Literature DB >> 8858049 |
D E Bredesen1, M Wiedau-Pazos, J J Goto, S Rabizadeh, J A Roe, E B Gralla, L M Ellerby, J S Valentine.
Abstract
Mutations in copper-zinc superoxide dismutase (CuZnSOD) that are associated with familial ALS (FALS) are dominant, gain-of-function mutations, but the nature of the function gained has not been identified. In addition to catalyzing the dismutation of superoxide, copper-zinc superoxide dismutase also displays peroxidase activity. Whereas mutants A4V and G93A retained superoxide dismutase activity, they demonstrated a markedly enhanced copper-dependent peroxidase activity in comparison with that of the wild type enzyme as detected by the spin trap 5,5'-dimethyl-1-pyrroline N-oxide (DMPO) in electron paramagnetic resonance measurements. Two copper chelators, diethyldithiocarbamate and penicillamine, inhibited the mutants' peroxidase activity, but not that of the wild type enzyme, at stoichiometric concentrations; furthermore, these copper chelators enhanced neural survival in a cell-culture model of ALS but did not alter survival of cells expressing only wild type copper-zinc superoxide dismutase. These observations suggest that oxidative reactions catalyzed by mutant copper-zinc superoxide dismutases may initiate the neuropathologic changes of FALS.Entities:
Mesh:
Substances:
Year: 1996 PMID: 8858049 DOI: 10.1212/wnl.47.4_suppl_2.36s
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 9.910